|
|
|
Small Stocks, Big Money™
|
|
Weekly Newsletter
|
|
|
|
|
|
|
|
Genius Group Completes FatBrain AI Merger, 150% Increase in 2023 Combined Proforma Revenue Guidance
Genius Group (NYSE American: GNS), a leading entrepreneur edtech and education group, and FatBrain AI (“FatBrain AI”), an AI SaaS and Solutions company (OTCMKTS:LZGI), announced completion of their merger to form an AI-powered Education and Acceleration group to power Sovereign AI ecosystems of tomorrow for entrepreneurs, enterprises, governments and students through AI education and enablement. Following NYSE approval, Genius Group completed the merger, acquiring FatBrain AI in an all-stock transaction. Under the terms of the agreement, Genius Group has acquired the AI software assets, customer relationships and specific operations of FatBrain AI, with an anticipated increase of approximately 150% in the Company’s 2023 pro forma revenue guidance to an estimated $76 million to $80 million, and an anticipated increase of $4 million in pro forma net profit guidance to $7 million to $9 million.
|
|
|
|
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
Zomedica (NYSE American: ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, announced the publication of a peer-reviewed research study favorably comparing the capabilities for the diagnosis of feline hyperthyroidism of its novel, point-of-care TRUFORMA Bulk Acoustic Wave (BAW) diagnostic platform to chemiluminescent immunoassay (CLIA) platforms currently broadly utilized by reference laboratories globally. "We are grateful to have the support of Dr. Peterson and his colleagues in validating the TRUFORMA platform as the state of the art for in-clinic diagnosis of feline hyperthyroidism," commented Larry Heaton, Zomedica's Chief Executive Officer.
|
|
|
|
|
Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe
Greenwich LifeSciences, (Nasdaq: GLSI), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, announced the initiation of the first clinical sites in Europe in collaboration with GEICAM in Spain. The Company has partnered with GEICAM, the largest academic breast cancer research network in Spain, where 38 hospitals have agreed to participate in FLAMINGO-01. These sites were recently approved by Spanish authorities, which led to site initiation visits and training of the first sites this past week.
|
|
|
|
|
|
|
Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results
Soligenix (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced its recent accomplishments and financial results for the year ended December 31, 2023. "Our primary focus in 2024 continues to be advancing our multiple clinical programs in our rare disease pipeline," stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix. “With approximately $8.4 million in cash at December 31, 2023, not including our non-dilutive government funding, we are managing cash burn very carefully in order to achieve our near-term milestones.”
|
|
|
|
|
American Resources Corporation's ReElement Technologies Joins Forces With EDP Renewables to Pioneer Sustainable Rare Earth Magnet Recycling
American Resources Corp.’s (Nasdaq: AREC) wholly owned subsidiary, ReElement Technologies Corporation, ("ReElement") a leading provider of high performance refining capacity of rare earth and critical battery elements, announced a partnership with EDP Renewables North America ("EDPR NA"), a North American leader in the renewable energy sector, to advance sustainable practices in the wind energy sector through the EDPR NA's newly launched Close the Loop Program. The focus of this collaboration is efficient and sustainable recycling of neodymium-based permanent magnets from decommissioned wind turbines into magnet-grade rare earth elements, contributing to the development of a truly circular supply chain for renewable energy equipment and inputs.
|
|
|
|
|
|
Small Stocks, Big Money™ Podcast
The podcast features in-depth interviews with CEO’s from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
Available on:
|
|
|
|
Upcoming Events
|
|
|
NYSE AMERICAN: UMAC - Unusual Machines
4:15pm Eastern
Unusual Machines is focused on becoming a first-person view (FPV) drone technology market leader.
|
|
|
|
OTC: CBDW - 1606 Corp
4:15pm Eastern
1606 Corp. (OTC: CBDW) stands at the forefront of technological innovation in the online CBD industry.
|
|
|
|
NASDAQ: ENLV - Enlivex Therapeutics
11:00am Eastern
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses.
|
|
|
|
NASDAQ: ASPI - ASP Isotopes
4:15pm Eastern
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries.
|
|
|
|
Archived Events
|
|
|
NASDAQ: BFRG - BullFrog AI
4:15pm Eastern
BullFrog AI is a technology enabled drug development company using machine learning to usher in a new era of precision medicine.
|
|
|
|
Quote of the Week
|
"Small caps outperform not because of market capitalization alone but because the stocks in this category are least efficiently priced."
|
|
|
— James O’Shaughnessy, Author of What Works on Wall Street
|
|
|
|
|
RedChip TV
|
|
|
|
RedChip TV Highlights Mobilicom Limited (NASDAQ : MOB) & Lytus Technologies (NASDAQ: LYT) This Week
|
|
|
|
|
|
AI-Powered Customer Service: 1606 Corp. (OTC: CBDW) in Online CBD
|
|
|
|
|
|
|
Order "Small Stocks, Big Money™ Today!
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
|
|
|
|
|
|
|
Lesson of the Week
What does the fifth letter on a symbol mean? Find out in this week's lesson.
|
|
|
|
|
|
MidSouth Week in Review
A report on consumer prices showed inflation remains stubborn, ticking up to 3.2% in February from 3.1% in January.
|
|
|
|
|
|
|
|
